There’s less off the attention-deficit disorder drug Adderall available to the public than there used to be: some even call it a shortage. The company blames the FDA, which has limited the total amount of the drug manufactured: it is, after all, an amphetamine and a controlled substance. Manufacturer Shire has responded to these limits by… hiking the price and making fewer discounts available to consumers. [More]
